Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 7Brain Neoplasms 4Pain 2Neuralgia 2Glioma 2Depression 2Visceral Pain 1Recurrence 1Rectal Neoplasms 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Neurologic Manifestations 1Lymphoma, Follicular 1Language Disorders 1Headache 1Glioblastoma 1Fatigue 1Depressive Disorder, Major 1Cognitive Dysfunction 1Carcinoma, Renal Cell 1Cancer Survivor 1Anxiety Disorders 1Agnosia 1Acromegaly 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Transcranial Magnetic Stimulation × Clear all
NCT00324428 2017-03-21

TMS for the Treatment of Pancreatic Cancer Pain

Beth Israel Deaconess Medical Center

Phase NA Completed
3 enrolled
Gastrointestinal

Agnosia, Neoplasms, Pain, Pancreatic Neoplasms, Visceral Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡